Orlistat is a well-known irreversible inhibitor of pancreatic and gastric lipase, as well as a fatty acid synthase inhibitor [5], and it is commonly used to treat obesity and prevent atherosclerosis. This evidence concerns the gene LIPF and obesity disorder.